Aptevo Therapeutics Announces IND Submission for APVO436

    NEXT STORY
    Trinity Biotech announces Results for Q1, 2018
    PREV STORY
    MPI – Publication of Merger Prospectus
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Teladoc Health Reports Fourth-Quarter and Full-Year 2018 Results

    author_avatar
    NASDAQ Market News

    RedHill Biopharma Announces Unanimous Positive DSMB Recommendation for Continuation of the Phase III Study with RHB-104 for Crohn’s Disease

    The independent Data and Safety Monitoring Board (DSMB) reviewed safety and efficacy data, of ...

    author_avatar
    NASDAQ Market News

    Loxo Oncology Announces First Pediatric Response to LOXO-101

    - Peer-Reviewed Case Report Published in Pediatric Blood and Cancer - - LOXO-101 Induces ...

    author_avatar
    NASDAQ Market News